Header cover image

French (CAC) Healthcare Sector Analysis

UpdatedApr 12, 2024
DataAggregated Company Financials
Companies64
  • 7D-1.1%
  • 3M-0.03%
  • 1Y-3.7%
  • YTD1.7%

Over the last 7 days, the Healthcare industry has remained flat, although notably bioMérieux gained 5.5%. Furthermore, the industry has been flat for the past year as well. As for the next few years, earnings are expected to grow by 15% per annum.

Sector Valuation and Performance

Has the French Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sat, 13 Apr 2024€270.4b€104.7b€8.5b20.5x31.7x2.6x
Mon, 11 Mar 2024€272.2b€104.7b€8.6b21.2x31.8x2.6x
Wed, 07 Feb 2024€259.1b€104.7b€9.0b21.1x28.7x2.5x
Fri, 05 Jan 2024€264.5b€104.0b€12.7b21.6x20.8x2.5x
Sun, 03 Dec 2023€250.0b€104.0b€12.7b20.5x19.7x2.4x
Tue, 31 Oct 2023€237.6b€104.2b€12.8b20.3x18.6x2.3x
Thu, 28 Sep 2023€267.3b€105.0b€12.5b20.9x21.4x2.5x
Sat, 26 Aug 2023€272.7b€104.8b€12.4b22.5x22x2.6x
Mon, 24 Jul 2023€275.6b€103.6b€12.3b19.5x22.3x2.7x
Wed, 21 Jun 2023€265.9b€103.8b€12.4b20.5x21.4x2.6x
Fri, 19 May 2023€278.3b€108.3b€12.1b20.9x23x2.6x
Sun, 16 Apr 2023€279.4b€107.8b€12.3b20.4x22.7x2.6x
Tue, 14 Mar 2023€255.1b€107.8b€12.7b19.3x20.2x2.4x
Thu, 09 Feb 2023€268.5b€105.9b€10.8b18.6x24.8x2.5x
Sat, 07 Jan 2023€267.6b€104.9b€10.5b17.7x25.5x2.6x
Mon, 05 Dec 2022€269.2b€105.1b€10.5b18.6x25.7x2.6x
Wed, 02 Nov 2022€256.4b€104.9b€10.2b17.9x25.1x2.4x
Fri, 30 Sep 2022€170.4b€79.5b€8.6b16.6x19.8x2.1x
Sun, 28 Aug 2022€191.5b€78.9b€9.0b20.6x21.2x2.4x
Tue, 26 Jul 2022€211.2b€76.7b€9.2b20.4x23.1x2.8x
Thu, 23 Jun 2022€196.7b€76.6b€9.1b19.1x21.7x2.6x
Sat, 21 May 2022€212.4b€75.5b€9.2b19.3x23.1x2.8x
Mon, 18 Apr 2022€220.7b€74.4b€8.8b19.6x25.1x3x
Wed, 16 Mar 2022€204.9b€73.7b€8.5b18.9x24x2.8x
Fri, 11 Feb 2022€209.0b€72.4b€8.6b18.7x24.4x2.9x
Sun, 09 Jan 2022€216.9b€71.8b€8.5b23x25.5x3x
Tue, 07 Dec 2021€216.1b€71.8b€8.5b21.8x25.4x3x
Thu, 04 Nov 2021€228.8b€71.7b€8.5b24x26.9x3.2x
Sat, 02 Oct 2021€213.2b€70.5b€8.1b22.4x26.4x3x
Mon, 30 Aug 2021€232.1b€70.2b€8.1b26.3x28.7x3.3x
Tue, 06 Jul 2021€212.5b€70.2b€8.1b26.6x26.3x3x
Price to Earnings Ratio

14.6x


Total Market Cap: €207.2bTotal Earnings: €14.2bTotal Revenue: €68.5bTotal Market Cap vs Earnings and Revenue0%0%0%
French Healthcare Sector Price to Earnings3Y Average 23.5x202220232024
Current Industry PE
  • Investors are optimistic on the French Healthcare industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 31.9x which is higher than its 3-year average PE of 23.5x.
  • The industry is trading close to its 3-year average PS ratio of 2.7x.
Past Earnings Growth
  • The earnings for companies in the Healthcare industry have declined 16% per year over the last three years.
  • Meanwhile revenues for these companies have grown 15% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the French Healthcare sector?

FR Market-1.81%
Healthcare-1.08%
Healthtech4.19%
Biotech3.29%
Medical Equipment-0.16%
Life Sciences-1.11%
Pharma-1.98%
Healthcare Services-3.25%
Industry PE
  • Investors are most optimistic about the Life Sciences industry which is trading above its 3-year average PE ratio of 38.5x.
    • Analysts are expecting annual earnings growth of 20.6%, which is higher than its past year's earnings decline of 55.8% per year.
Forecasted Growth
  • Analysts are most optimistic on the Healthcare Services industry, expecting annual earnings growth of 59% over the next 5 years.
  • This is better than its past earnings decline of 37% per year.
  • In contrast, the Pharma industry is expected to see its earnings grow by 13% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
BIM bioMérieux€104.6010.0%
+€1.1b
7.8%PE34.6x
ERF Eurofins Scientific€59.802.2%
+€249.9m
-3.6%PE44.8x
IPN Ipsen€109.401.9%
+€165.2m
2.4%PE14.6x
ORP Orpea€10.932.9%
+€48.7m
-99.6%PS0.4x
VIRP Virbac€365.001.5%
+€46.0m
24.8%PE25.2x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

ALMDT

€3.87

Median Technologies

7D

58.6%

1Y

-50.5%

BIM

€104.60

bioMérieux

7D

10.0%

1Y

7.8%

ABVX

€13.78

ABIVAX Société Anonyme

7D

-2.7%

1Y

37.9%

EQS

€61.00

Equasens Société anonyme

7D

2.7%

1Y

-15.7%

SAN

€86.47

Sanofi

7D

-1.0%

1Y

-15.3%

VIRP

€365.00

Virbac

7D

1.5%

1Y

24.8%

ERF

€59.80

Eurofins Scientific

7D

2.2%

1Y

-3.6%

ORP

€10.93

Orpea

7D

2.9%

1Y

-99.6%

DIM

€250.60

Sartorius Stedim Biotech

7D

-0.5%

1Y

-13.5%

GBT

€33.50

Guerbet

7D

-3.7%

1Y

96.6%

AMPLI

€3.00

Amplitude Surgical

7D

-10.7%

1Y

-6.8%

NANO

€5.24

Nanobiotix

7D

-8.2%

1Y

48.9%